Psychedelic treatment for depression is on sale for the first timeByOlivia Goldhill and Olivia Goldhill
The business interests behind vaccine trials work against people of colorByOlivia Goldhill and Olivia Goldhill
UK scientists are pushing for the world’s first coronavirus challenge trialsByOlivia Goldhill and Olivia Goldhill
With every reversal of Covid-19 guidance, the CDC is losing the battle for public trustByOlivia Goldhill and Olivia Goldhill
US freezers aren’t cold enough to store one major coronavirus vaccineByOlivia Goldhill and Olivia Goldhill
The number of uninsured Americans was up even before the pandemicByOlivia Goldhill and Olivia Goldhill
The disproportionate mental health effects of Covid-19 on Black and Latino populationsByOlivia Goldhill and Olivia Goldhill
Covid-19 vaccines could be distributed through churches, beauty salons, and poultry farmsByOlivia Goldhill and Olivia Goldhill
Scientists are trying to explain why so few Kenyans are dying of coronavirusByOlivia Goldhill and Olivia Goldhill
Healthcare experts debate whether to hand out vaccines based on raceByOlivia Goldhill and Olivia Goldhill
The pandemic is making women reconsider when and if to have babiesByOlivia Goldhill and Olivia Goldhill
The UK tested a classic psychological tactic by paying 64 million restaurant billsByOlivia Goldhill and Olivia Goldhill
Australia won’t be the last country to wrestle with a mandatory coronavirus vaccineByOlivia Goldhill and Olivia Goldhill
It could take 8,000 cargo plane loads to ship Covid-19 vaccines around the worldByOlivia Goldhill and Olivia Goldhill
Once US healthcare workers get a coronavirus vaccine, who will be next?ByOlivia Goldhill and Olivia Goldhill
Ketamine’s promise as an antidepressant is being undermined by its lack of profitByOlivia Goldhill and Olivia Goldhill
